Revolutionizing Clinical Pain Research: A Shift Toward Patient-centered Engagement

The Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT), including Simon Haroutounian, PhD, MSc, and Katie Holzer, PhD, LCSW, brought together a diverse group of participants from academia, industry, funding and regulatory agencies, and people with lived experience (PWLE) of pain, to developed recommendations for advancing patient engagement in clinical pain research.

Advancing Pain Research: Highlights from the Inaugural St. Louis Translational Pain Forum (Links to an external site)

The inaugural St. Louis Translational Pain Forum (STL-TPRF) was brought to fruition through a collaborative effort between the Washington University Pain Center, the Institute for Translational Neuroscience at Saint Louis University, and the Center for Clinical Pharmacology – a joint venture between UHSP and the Department of Anesthesiology at Washington University School of Medicine in St. Louis.

Diminish Discomfort with Pain Psychology

When people think of pain management, they often think of pain pills; however, there are many other treatments available. One of those options is pain psychology. Sarah K. Buday, PhD, provides valuable insight into what pain psychology is and how it can improve a patient’s pain.

Moron-Concepcion appointed to NIH advisory board (Links to an external site)

Jose Moron-Concepcion, PhD, the Henry E. Mallinckrodt Professor of Anesthesiology at Washington University School of Medicine in St. Louis, has been appointed to a four-year term on the National Advisory Dental and Craniofacial Research Council. The council is an extension of the National Institute for Dental and Craniofacial Research at the National Institutes of Health (NIH).

COVID-19 infection linked to higher risk of neuropathy symptoms (Links to an external site)

Adding to a growing body of evidence that, for many, problems related to COVID-19 linger longer than the initial infection, researchers at Washington University School of Medicine in St. Louis have found that some people infected during the pandemic’s early months experienced symptoms of peripheral neuropathy — pain, tingling and numbness in the hands and feet — during and following their bouts with the virus.

Blocking opioid receptor restores motivation in chronic pain patients (Links to an external site)

What if it were possible to develop a pain killer that could curb the negative emotions associated with pain without causing euphoria? Researchers at Washington University School of Medicine in St. Louis have taken a step toward that goal. Studying rodents, they have shown they can block receptors in the brain responsible for the emotional components of pain and restore the animal’s motivation. Their findings could lay the groundwork for developing new, less addictive approaches to pain treatment.